What’s more, overall survival (OS), progression-free interval (PFI) and disease specific survival (DSS) curves of AKR1B1 in pan-cancer from TCGA database showed that tumor patients with high expression of AKR1B1 had worse prognosis (Fig. 1B). Here, AKR1B1 is linked to cancer.